139 related articles for article (PubMed ID: 38844245)
21. PRKCG mutation (SCA-14) causing a Ramsay Hunt phenotype.
Visser JE; Bloem BR; van de Warrenburg BP
Mov Disord; 2007 May; 22(7):1024-6. PubMed ID: 17343273
[TBL] [Abstract][Full Text] [Related]
22. Expanding the Phenotype and Genetic Defects Associated with the
Praschberger R; Balint B; Mencacci NE; Hersheson J; Rubio-Agusti I; Kullmann DM; Bettencourt C; Bhatia K; Houlden H
Mov Disord Clin Pract; 2015 Sep; 2(3):271-273. PubMed ID: 30363482
[TBL] [Abstract][Full Text] [Related]
23. Progressive myoclonus epilepsy without renal failure in a Chinese family with a novel mutation in SCARB2 gene and literature review.
Tian WT; Liu XL; Xu YQ; Huang XJ; Zhou HY; Wang Y; Tang HD; Chen SD; Luan XH; Cao L
Seizure; 2018 Apr; 57():80-86. PubMed ID: 29605618
[TBL] [Abstract][Full Text] [Related]
24. Novel Genetic and Phenotypic Expansion in
Hentrich L; Parnes M; Lotze TE; Coorg R; de Koning TJ; Nguyen KM; Yip CK; Jungbluth H; Koy A; Dafsari HS
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895210
[TBL] [Abstract][Full Text] [Related]
25. Exome sequencing reveals a novel MRE11 mutation in a patient with progressive myoclonic ataxia.
Miyamoto R; Morino H; Yoshizawa A; Miyazaki Y; Maruyama H; Murakami N; Fukada K; Izumi Y; Matsuura S; Kaji R; Kawakami H
J Neurol Sci; 2014 Feb; 337(1-2):219-23. PubMed ID: 24332946
[TBL] [Abstract][Full Text] [Related]
26. IRF2BPL as a novel causative gene for progressive myoclonus epilepsy.
Gardella E; Michelucci R; Christensen HM; Fenger CD; Reale C; Riguzzi P; Pasini E; Albini-Riccioli L; Papa V; Foschini MP; Cenacchi G; Furia F; Marjanovic D; Hammer TB; Møller RS; Rubboli G
Epilepsia; 2023 Aug; 64(8):e170-e176. PubMed ID: 37114479
[TBL] [Abstract][Full Text] [Related]
27. Nationwide survey in Japan endorsed diagnostic criteria of benign adult familial myoclonus epilepsy.
Kobayashi K; Hitomi T; Matsumoto R; Watanabe M; Takahashi R; Ikeda A
Seizure; 2018 Oct; 61():14-22. PubMed ID: 30053653
[TBL] [Abstract][Full Text] [Related]
28. Conventional and novel anti-seizure medications reveal a particular role for GABA
Polet SS; de Koning TJ; Lambrechts RA; Tijssen MAJ; Sibon OCM; Gorter JA
Epilepsy Res; 2024 Jul; 203():107380. PubMed ID: 38781737
[TBL] [Abstract][Full Text] [Related]
29. Familial cortical myoclonic tremor as a unique form of cortical reflex myoclonus.
Terada K; Ikeda A; Mima T; Kimura M; Nagahama Y; Kamioka Y; Murone I; Kimura J; Shibasaki H
Mov Disord; 1997 May; 12(3):370-7. PubMed ID: 9159732
[TBL] [Abstract][Full Text] [Related]
30. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
31. Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2.
Guerrini R; Bonanni P; Patrignani A; Brown P; Parmeggiani L; Grosse P; Brovedani P; Moro F; Aridon P; Carrozzo R; Casari G
Brain; 2001 Dec; 124(Pt 12):2459-75. PubMed ID: 11701600
[TBL] [Abstract][Full Text] [Related]
32. 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation.
Boissé Lomax L; Bayly MA; Hjalgrim H; Møller RS; Vlaar AM; Aaberg KM; Marquardt I; Gandolfo LC; Willemsen M; Kamsteeg EJ; O'Sullivan JD; Korenke GC; Bloem BR; de Coo IF; Verhagen JM; Said I; Prescott T; Stray-Pedersen A; Rasmussen M; Vears DF; Lehesjoki AE; Corbett MA; Bahlo M; Gecz J; Dibbens LM; Berkovic SF
Brain; 2013 Apr; 136(Pt 4):1146-54. PubMed ID: 23449775
[TBL] [Abstract][Full Text] [Related]
33. Familial cortical myoclonus with a mutation in NOL3.
Russell JF; Steckley JL; Coppola G; Hahn AF; Howard MA; Kornberg Z; Huang A; Mirsattari SM; Merriman B; Klein E; Choi M; Lee HY; Kirk A; Nelson-Williams C; Gibson G; Baraban SC; Lifton RP; Geschwind DH; Fu YH; Ptáček LJ
Ann Neurol; 2012 Aug; 72(2):175-83. PubMed ID: 22926851
[TBL] [Abstract][Full Text] [Related]
34. Significance and clinical suggestions for the somatosensory evoked potentials increased in amplitude revealed by a large sample of neurological patients.
Rossi Sebastiano D; Cazzato D; Visani E; Dalla Bella E; Brambilla L; Devigili G; Caroppo P; Maggi L; Nanetti L; Salsano E; Canafoglia L; Canavero I; Anghileri E; Bonfoco D; Lanteri P
Neurol Sci; 2022 Sep; 43(9):5553-5562. PubMed ID: 35759065
[TBL] [Abstract][Full Text] [Related]
35. Non-convulsive Status Epilepticus in
Duan J; Chen Y; Hu Z; Ye Y; Zhang T; Li C; Zeng Q; Zhao X; Mai J; Sun Y; Liu C; Zheng W; Xiao Y; Liao J; Chen L
Front Pediatr; 2022; 10():859183. PubMed ID: 35573939
[TBL] [Abstract][Full Text] [Related]
36. Early onset ataxia with comorbid myoclonus and epilepsy: A disease spectrum with shared molecular pathways and cortico-thalamo-cerebellar network involvement.
van Noort SAM; van der Veen S; de Koning TJ; de Koning-Tijssen MAJ; Verbeek DS; Sival DA
Eur J Paediatr Neurol; 2023 Jul; 45():47-54. PubMed ID: 37301083
[TBL] [Abstract][Full Text] [Related]
37. Report of progressive myoclonus ataxia (PMA) in two Chinese pedigrees.
Sun L; Wu J; Liu C; Lin W
Neurol Res; 2016 Oct; 38(10):893-6. PubMed ID: 27342741
[TBL] [Abstract][Full Text] [Related]
38. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
Nascimento FA; Andrade DM
Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
[TBL] [Abstract][Full Text] [Related]
39. DHDDS and NUS1: A Converging Pathway and Common Phenotype.
Williams LJ; Waller S; Qiu J; Innes E; Elserafy N; Procopis P; Sampaio H; Mahant N; Tchan MC; Mohammad SS; Morales-Briceño H; Fung VSC
Mov Disord Clin Pract; 2024 Jan; 11(1):76-85. PubMed ID: 38291835
[TBL] [Abstract][Full Text] [Related]
40. De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus.
Galosi S; Edani BH; Martinelli S; Hansikova H; Eklund EA; Caputi C; Masuelli L; Corsten-Janssen N; Srour M; Oegema R; Bosch DGM; Ellis CA; Amlie-Wolf L; Accogli A; Atallah I; Averdunk L; Barañano KW; Bei R; Bagnasco I; Brusco A; Demarest S; Alaix AS; Di Bonaventura C; Distelmaier F; Elmslie F; Gan-Or Z; Good JM; Gripp K; Kamsteeg EJ; Macnamara E; Marcelis C; Mercier N; Peeden J; Pizzi S; Pannone L; Shinawi M; Toro C; Verbeek NE; Venkateswaran S; Wheeler PG; Zdrazilova L; Zhang R; Zorzi G; Guerrini R; Sessa WC; Lefeber DJ; Tartaglia M; Hamdan FF; Grabińska KA; Leuzzi V
Brain; 2022 Mar; 145(1):208-223. PubMed ID: 34382076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
